It is noteworthy that the publicly available databases we utilized did not provide detailed clinical baseline information about the patients, such as age, sex, and precise genetic subtypes of B-ALL (e.g., Ph+, Ph-like, MLL rearrangements). Here, KMT2A is linked to precursor B-cell acute lymphoblastic leukemia.